Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 L’Oréal Issues Recall of Effaclar Duo - Happi
Regulations

L’Oréal Issues Recall of Effaclar Duo

Lab testing found high levels of benzene in acne treatments.

In response to lab testing, L’Oreal has issued a voluntary recall of its Effaclar Duo in the U.S.

According to the recall, independent U.S. lab Valisure found high levels of benzene in acne treatments containing benzoyl peroxide (BPO) made by several companies. A larger list was revealed on the FDA website, as seen here.

The recall noted that benzene is a known carcinogen that can form at high levels in products containing BPO, a common ingredient for killing acne-causing bacteria.

The Effaclar Duo is a La Roche-Posay acne treatment that contains BPO.

The Happi Top 30 company stated that the recall will assist in a “seamless transition” to its new and improved Effaclar Duo formula, which has been in development since 2024.

In this recent round of testing, high levels of benzene were found in the air around incubated BPO products, showing that benzene can leak out of some product packages and pose a potential inhalation risk, said the recall.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters